Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2Gastrointestinal 2

Conditions

Urinary Bladder Neoplasms 13Colorectal Neoplasms 9Neoplasm Metastasis 8Peritoneal Neoplasms 6Pancreatic Neoplasms 6Non-Muscle Invasive Bladder Neoplasms 6Appendiceal Neoplasms 6Stomach Neoplasms 5Carcinoma, Hepatocellular 5Anus Neoplasms 5Sarcoma 4Rectal Neoplasms 4Colonic Neoplasms 4Liver Neoplasms 3Carcinoma, Transitional Cell 3Pseudomyxoma Peritonei 2Mesothelioma, Malignant 2Lung Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms 2Anal Canal Carcinoma 2Urothelial Carcinoma of the Bladder 1Urologic Neoplasms 1Urologic Diseases 1Urinary Bladder Diseases 1Urethral Neoplasms 1Ureteral Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Pleural Neoplasms 1Pancoast Syndrome 1

Interventions

Mitomycin 2Capecitabine 2Tacrolimus 1Specimen Handling 1Sirolimus 1Nivolumab 1Magnetic Resonance Spectroscopy 1Lansoprazole 1Ipilimumab 1Hyperthermic Intraperitoneal Chemotherapy 1Cytoreduction Surgical Procedures 1Clarithromycin 1CTLA-4 Antigen 1Bromelains 1Amoxicillin 1Alemtuzumab 1Acetylcysteine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Pseudomyxoma Peritonei × Mitomycin × Clear all
NCT04779554 2026-04-01

Flat Dose vs. Weight-based IP Chemotherapy for CRS/HIPEC

University of Kentucky

Phase 2 Recruiting
100 enrolled
GastrointestinalGynecologic

Appendiceal Neoplasms, Peritoneal Neoplasms, Pseudomyxoma Peritonei, Colorectal Neoplasms

NCT02040142 2024-10-24

HIPEC for Peritoneal Carcinomatosis

Albert Einstein College of Medicine

Phase 2 Completed
51 enrolled 12 charts
GastrointestinalGynecologic

Appendiceal Neoplasms, Peritoneal Neoplasms, Pseudomyxoma Peritonei, Stomach Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡